Skip to main content

and
  1. No Access

    Article

    Chemotherapy-induced peripheral neuropathy (CIPN) and its treatment: an NIH Collaboratory study of claims data

    Chemotherapy-induced peripheral neuropathy (CIPN) is a disabling complication of many chemotherapies. We investigated the feasibility of using health plan claims and administrative data to identify CIPN occurr...

    Jennifer S. Gewandter, Amber S. Kleckner, James H. Marshall in Supportive Care in Cancer (2020)

  2. No Access

    Article

    Factors associated with falls in older adults with cancer: a validated model from the Cancer and Aging Research Group

    Falls in older adults with cancer are common, yet factors associated with fall-risk are not well-defined and may differ from the general geriatric population. This study aims to develop and validate a model of...

    Tanya M. Wildes, Ronald J. Maggiore, William P. Tew in Supportive Care in Cancer (2018)

  3. No Access

    Article

    A phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study of 462 cancer survivors

    Chemotherapy-induced peripheral neuropathy (CIPN) occurs in as high as 70 % of patients receiving certain types of chemotherapy agents. The FDA has yet to approve a therapy for CIPN. The aim of this multicente...

    Jennifer S. Gewandter, Supriya G. Mohile, Charles E. Heckler in Supportive Care in Cancer (2014)

  4. No Access

    Article

    Bone health issues in breast cancer survivors: a Medicare Current Beneficiary Survey (MCBS) study

    Breast cancer treatments (chemotherapy and hormone therapy) can cause a rapid loss in bone mineral density, leading to osteoporosis and fractures later in life. Fortunately, preventative measures (vitamin D, e...

    Luke J. Peppone, Karen M. Mustian, Randy N. Rosier in Supportive Care in Cancer (2014)

  5. No Access

    Article

    Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research

    Altered levels of cytokines and chemokines may play a role in cancer- and cancer treatment-related cognitive difficulties. In many neurodegenerative diseases, abnormal concentrations of cytokines and chemokine...

    Michelle C. Janelsins, Karen M. Mustian, Oxana G. Palesh in Supportive Care in Cancer (2012)